284 related articles for article (PubMed ID: 28431965)
1. Origin of Nanodroplet Formation Upon Dissolution of an Amorphous Solid Dispersion: A Mechanistic Isotope Scrambling Study.
Indulkar AS; Waters JE; Mo H; Gao Y; Raina SA; Zhang GGZ; Taylor LS
J Pharm Sci; 2017 Aug; 106(8):1998-2008. PubMed ID: 28431965
[TBL] [Abstract][Full Text] [Related]
2. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
Purohit HS; Taylor LS
Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
[TBL] [Abstract][Full Text] [Related]
3. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic elucidation of formation of drug-rich amorphous nanodroplets by dissolution of the solid dispersion formulation.
Ueda K; Higashi K; Moribe K
Int J Pharm; 2019 Apr; 561():82-92. PubMed ID: 30822504
[TBL] [Abstract][Full Text] [Related]
5. Impact of polymers on the crystallization and phase transition kinetics of amorphous nifedipine during dissolution in aqueous media.
Raina SA; Alonzo DE; Zhang GG; Gao Y; Taylor LS
Mol Pharm; 2014 Oct; 11(10):3565-76. PubMed ID: 25185035
[TBL] [Abstract][Full Text] [Related]
6. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
Indulkar AS; Lou X; Zhang GGZ; Taylor LS
Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
[TBL] [Abstract][Full Text] [Related]
7. Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.
Verma S; Rudraraju VS
AAPS PharmSciTech; 2015 Oct; 16(5):1079-90. PubMed ID: 25672820
[TBL] [Abstract][Full Text] [Related]
8. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
Jackson MJ; Kestur US; Hussain MA; Taylor LS
Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
[TBL] [Abstract][Full Text] [Related]
9. Hypromellose acetate succinate based amorphous solid dispersions via hot melt extrusion: Effect of drug physicochemical properties.
Sarabu S; Kallakunta VR; Bandari S; Batra A; Bi V; Durig T; Zhang F; Repka MA
Carbohydr Polym; 2020 Apr; 233():115828. PubMed ID: 32059882
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Polymers with Enzalutamide Nanodroplets-Impact on Droplet Properties and Induction Times.
Wilson VR; Mugheirbi NA; Mosquera-Giraldo LI; Deac A; Moseson DE; Smith DT; Novo DC; Borca CH; Slipchenko LV; Edgar KJ; Taylor LS
Mol Pharm; 2021 Mar; 18(3):836-849. PubMed ID: 33539105
[TBL] [Abstract][Full Text] [Related]
11. Influence of mechanical and thermal energy on nifedipine amorphous solid dispersions prepared by hot melt extrusion: Preparation and physical stability.
Ma X; Huang S; Lowinger MB; Liu X; Lu X; Su Y; Williams RO
Int J Pharm; 2019 Apr; 561():324-334. PubMed ID: 30858115
[TBL] [Abstract][Full Text] [Related]
12. Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers.
Friedrich H; Nada A; Bodmeier R
Drug Dev Ind Pharm; 2005 Sep; 31(8):719-28. PubMed ID: 16221606
[TBL] [Abstract][Full Text] [Related]
13. Dissolution and precipitation behavior of amorphous solid dispersions.
Alonzo DE; Gao Y; Zhou D; Mo H; Zhang GGZ; Taylor LS
J Pharm Sci; 2011 Aug; 100(8):3316-3331. PubMed ID: 21607951
[TBL] [Abstract][Full Text] [Related]
14. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel S; Cathcart H; O'Reilly NJ
Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
[TBL] [Abstract][Full Text] [Related]
15. Polymer Type Impacts Amorphous Solubility and Drug-Rich Phase Colloidal Stability: A Mechanistic Study Using Nuclear Magnetic Resonance Spectroscopy.
Ueda K; Taylor LS
Mol Pharm; 2020 Apr; 17(4):1352-1362. PubMed ID: 32097023
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mobility Suppression of Ibuprofen-Rich Amorphous Nanodroplets by HPMC Revealed by NMR Relaxometry and Its Significance with Respect to Crystallization Inhibition.
Ueda K; Yamamoto N; Higashi K; Moribe K
Mol Pharm; 2019 Dec; 16(12):4968-4977. PubMed ID: 31661287
[TBL] [Abstract][Full Text] [Related]
17. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions.
Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S
Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848
[TBL] [Abstract][Full Text] [Related]
18. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.
Saboo S; Mugheirbi NA; Zemlyanov DY; Kestur US; Taylor LS
J Control Release; 2019 Mar; 298():68-82. PubMed ID: 30731151
[TBL] [Abstract][Full Text] [Related]
19. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
Sarode AL; Malekar SA; Cote C; Worthen DR
Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
[TBL] [Abstract][Full Text] [Related]
20. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
